Biomerica (BMRA) Metrics: History & Chart

Biomerica, Inc.(BMRA)

Medical - Devices · Irvine, CA

$2.05-0.09 (-4.30%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Biomerica, Inc.

Biomerica, Inc. is a biomedical technology firm that invents, secures intellectual property for, produces, and globally distributes diagnostic and therapeutic solutions aimed at identifying and addressing a range of medical conditions and diseases. The company's diagnostic testing kits analyze patient samples, such as blood, urine, or stool, to pinpoint various illnesses and health complications. These kits are also capable of quantifying minute concentrations of specific substances like bacteria, hormones, antibodies, antigens, or other compounds present in bodily fluids or waste. Biomerica primarily sells its products for gastrointestinal disorders, food sensitivities, diabetes, and a variety of specialized diagnostic evaluations. Its distribution channels include physicians' clinics, retail pharmacies, and hospital/clinical laboratories. The company is currently developing InFoods, a diagnostic-guided therapy technology for irritable bowel syndrome; products for Helicobacter pylori; and comprehensive diagnostic tools for COVID-19, encompassing their development, testing, validation, and sale. Established in 1971, Biomerica, Inc. maintains its corporate headquarters in Irvine, California.

Irvine, CA

50 employees

www.biomerica.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Zackary S. Irani

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-14.23%
30D Total Return	-11.26%
YTD Total Return	-18.65%
1Y Total Return	-26.79%
3Y Total Return	-63.91%
5Y Total Return	-95.68%
10Y Total Return	-90.44%
15Y Total Return	-43.02%
20Y Total Return	-50.76%

2026	-18.65%
2025	+5.00%
2024	-76.00%
2023	-62.69%
2022	-13.88%
2021	-21.89%
2020

CAGR TTM	-26.68%
CAGR 3Y	-28.80%
CAGR 5Y	-46.66%
CAGR 10Y	-20.93%
CAGR 15Y	-3.68%
CAGR 20Y	-3.48%

PE Ratio	962.03
PE Ratio Avg TTM	95.35
PE Ratio Avg 3Y	84.10
Current VS TTM Avg	+908.92%
Current VS 3Y Avg	+1043.89%
Current VS 5Y Avg	+1197.08%

All Metrics

BMRA Valuation Metrics

BMRA Stock Price Metrics

BMRA Dividend Metrics

BMRA Growth Rate Metrics

BMRA Discounted Cash Flow Metrics

BMRA Returns By Period

BMRA Yearly Returns

BMRA Average Annual Returns By Period (CAGR)

BMRA Revenue Metrics

BMRA PE Ratio Metrics

BMRA PS Ratio Metrics

BMRA PB Ratio Metrics

BMRA Price to Free Cash Flow Ratio Metrics

BMRA Debt to Equity Ratio Metrics

BMRA PEG Ratio Metrics

BMRA FCF Yield

BMRA Earnings Yield

BMRA EBITDA Yield

BMRA OCF Yield

BMRA EV/EBIT Ratio Metrics

BMRA EV/EBITDA Ratio Metrics

BMRA EV/Assets Ratio Metrics

BMRA EV/Sales Ratio Metrics

BMRA Current Ratio Metrics

BMRA Quick Ratio Metrics

BMRA ROIC Metrics

BMRA Return on Assets Metrics

BMRA Return on Equity Metrics

BMRA Net Profit Margin Metrics

BMRA Gross Profit Margin Metrics

BMRA Tax Rate Metrics

PS Ratio	1.41
PS Ratio Avg TTM	1.41
PS Ratio Avg 3Y	9.94
Current VS TTM Avg	+0.32%
Current VS 3Y Avg	-85.82%
Current VS 5Y Avg	-90.07%

PB Ratio	2.39
PB Ratio Avg TTM	1.63
PB Ratio Avg 3Y	7.84
Current VS TTM Avg	+46.48%
Current VS 3Y Avg	-69.51%
Current VS 5Y Avg	-87.98%

PFCF Ratio	136.27
PFCF Ratio Avg TTM	129.84
PFCF Ratio Avg 3Y	129.84
Current VS TTM Avg	+4.96%
Current VS 3Y Avg	+4.96%
Current VS 5Y Avg	+4.96%

Debt/Equity Ratio	0.72
Debt/Equity Ratio Avg TTM	0.20
Debt/Equity Ratio Avg 3Y	0.10
Current VS TTM Avg	+250.24%
Current VS 3Y Avg	+631.53%
Current VS 5Y Avg	+464.37%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.73%
FCF Yield Avg TTM	0.78%
FCF Yield Avg 3Y	0.78%
Current VS TTM Avg	-6.71%
Current VS 3Y Avg	-6.71%
Current VS 5Y Avg	-6.71%

Earnings Yield	0.10%
Earnings Yield Avg TTM	1.05%
Earnings Yield Avg 3Y	1.16%
Current VS TTM Avg	-90.45%
Current VS 3Y Avg	-91.36%
Current VS 5Y Avg	-91.31%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	1895.19
Ev/Ebit Ratio Avg TTM	88.81
Ev/Ebit Ratio Avg 3Y	88.13
Current VS TTM Avg	+2034.02%
Current VS 3Y Avg	+2050.52%
Current VS 5Y Avg	+2150.86%

Ev/Ebitda Ratio	221.07
Ev/Ebitda Ratio Avg TTM	65.52
Ev/Ebitda Ratio Avg 3Y	64.65
Current VS TTM Avg	+237.41%
Current VS 3Y Avg	+241.97%
Current VS 5Y Avg	+212.68%

Ev/Assets Ratio	1.02
Ev/Assets Ratio Avg TTM	0.82
Ev/Assets Ratio Avg 3Y	5.47
Current VS TTM Avg	+24.79%
Current VS 3Y Avg	-81.34%
Current VS 5Y Avg	-92.32%

Ev/Sales Ratio	1.54
Ev/Sales Ratio Avg TTM	1.03
Ev/Sales Ratio Avg 3Y	9.39
Current VS TTM Avg	+49.77%
Current VS 3Y Avg	-83.60%
Current VS 5Y Avg	-88.67%

Current Ratio	1.62
Current Ratio Avg TTM	2.76
Current Ratio Avg 3Y	3.66
Current VS TTM Avg	-41.32%
Current VS 3Y Avg	-55.74%
Current VS 5Y Avg	-61.23%

Quick Ratio	0.93
Quick Ratio Avg TTM	1.87
Quick Ratio Avg 3Y	2.44
Current VS TTM Avg	-50.34%
Current VS 3Y Avg	-61.89%
Current VS 5Y Avg	-69.77%

ROIC	(117.93%)
ROIC Avg 3Y	(96.23%)
ROIC Avg 5Y	(84.20%)
Current VS 3Y Avg	-22.54%
Current VS 5Y Avg	-40.06%
Current VS 10Y Avg	-105.42%

ROA	(55.85%)
ROA Avg TTM	(18.33%)
ROA Avg 3Y	(17.07%)
Current VS TTM Avg	-204.68%
Current VS 3Y Avg	-227.19%
Current VS 5Y Avg	-243.19%

ROE	(143.54%)
ROE Avg TTM	(110.44%)
ROE Avg 3Y	(93.84%)
Current VS TTM Avg	-29.98%
Current VS 3Y Avg	-52.95%
Current VS 5Y Avg	-67.31%

Net Profit Margin	(84.79%)
Net Profit Margin Avg TTM	(115.77%)
Net Profit Margin Avg 3Y	(111.82%)
Current VS TTM Avg	+26.76%
Current VS 3Y Avg	+24.17%
Current VS 5Y Avg	+17.61%

Gross Profit Margin	8.09%
Gross Pft Margin Avg TTM	(2.04%)
Gross Pft Margin Avg 3Y	5.29%
Current VS TTM Avg	+496.20%
Current VS 3Y Avg	+53.03%
Current VS 5Y Avg	+19.46%

Tax Rate	60.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A